144 related articles for article (PubMed ID: 21414971)
21. Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats.
Jesmin S; Sakuma I; Hattori Y; Kitabatake A
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2021-6. PubMed ID: 12958045
[TBL] [Abstract][Full Text] [Related]
22. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
Wang C; Chen Z; Li Z; Cen J
Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
[TBL] [Abstract][Full Text] [Related]
23. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats.
Fujita A; Sasaki H; Doi A; Okamoto K; Matsuno S; Furuta H; Nishi M; Nakao T; Tsuno T; Taniguchi H; Nanjo K
Diabetes Res Clin Pract; 2008 Jan; 79(1):11-7. PubMed ID: 17897750
[TBL] [Abstract][Full Text] [Related]
24. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
25. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
Yu Y; Ohmori K; Chen Y; Sato C; Kiyomoto H; Shinomiya K; Takeuchi H; Mizushige K; Kohno M
J Am Coll Cardiol; 2004 Aug; 44(4):904-13. PubMed ID: 15312879
[TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of membrane type-1 matrix metalloproteinase in mesangial proliferative glomerulonephritis.
Hayashi K; Osada S; Shofuda K; Horikoshi S; Shirato I; Tomino Y
J Am Soc Nephrol; 1998 Dec; 9(12):2262-71. PubMed ID: 9848780
[TBL] [Abstract][Full Text] [Related]
27. Histopathological analyses of diabetic nephropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats.
Shin JH; So BI; Song YS; Lee Y; Jang KS; Kim H; Kim KS
Endocr Res; 2015; 40(1):29-36. PubMed ID: 24833322
[TBL] [Abstract][Full Text] [Related]
28. Renal expression of proto-oncogene Ets-1 on matrix remodeling in experimental diabetic nephropathy.
Liu DX; Liu XM; Su Y; Zhang XJ
Acta Histochem; 2011 Sep; 113(5):527-33. PubMed ID: 20598359
[TBL] [Abstract][Full Text] [Related]
29. Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses.
Niarakis A; Giannopoulou E; Ravazoula P; Panagiotopoulos E; Zarkadis IK; Aletras AJ
FEBS J; 2013 Dec; 280(24):6541-55. PubMed ID: 24112707
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of C-peptide on renal morphology in diabetic rats.
Sun W; Gao X; Zhao X; Cui D; Xia Q
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
[TBL] [Abstract][Full Text] [Related]
31. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
[TBL] [Abstract][Full Text] [Related]
32. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
33. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.
Takamiya Y; Fukami K; Yamagishi S; Kaida Y; Nakayama Y; Obara N; Iwatani R; Ando R; Koike K; Matsui T; Nishino Y; Ueda S; Cooper ME; Okuda S
Nephrol Dial Transplant; 2013 Jan; 28(1):55-62. PubMed ID: 23028104
[TBL] [Abstract][Full Text] [Related]
34. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
35. [Effects of MT1-MMP on the in vitro invasiveness of breast cancer cells].
Yao GY; Zeng MS; Lin P; Song LB; Zhang X; He JH; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):650-3. PubMed ID: 17274367
[TBL] [Abstract][Full Text] [Related]
36. Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
Yamagishi S; Koga K; Inagaki Y; Amano S; Okamoto T; Takeuchi M
Drugs Exp Clin Res; 2002; 28(6):221-7. PubMed ID: 12776575
[TBL] [Abstract][Full Text] [Related]
37. TNF-alpha induces MMP2 gelatinase activity and MT1-MMP expression in an in vitro model of nucleus pulposus tissue degeneration.
Séguin CA; Pilliar RM; Madri JA; Kandel RA
Spine (Phila Pa 1976); 2008 Feb; 33(4):356-65. PubMed ID: 18277865
[TBL] [Abstract][Full Text] [Related]
38. Amelioration of diabetic nephropathy in OLETF rats by prostaglandin I(2) analog, beraprost sodium.
Watanabe M; Nakashima H; Mochizuki S; Abe Y; Ishimura A; Ito K; Fukushima T; Miyake K; Ogahara S; Saito T
Am J Nephrol; 2009; 30(1):1-11. PubMed ID: 19158439
[TBL] [Abstract][Full Text] [Related]
39. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.
Schaefer L; Han X; August C; Matzkies F; Lorenz T; Schaefer RM
Diabetologia; 1997 Sep; 40(9):1035-43. PubMed ID: 9300240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
